[Skip to content]

Private Healthcare UK
Search our Site

This website is certified by Health On the Net Foundation. Click to verify.
This site complies with the HONcode standard for trustworthy health information:
verify here.

Advertisement
.

Temporary product intervention rules

FSA - Financial Services Authority

Under the Financial Services Bill, the incoming Financial Conduct Authority will have the power to make temporary product intervention rules. I

 

The FSA has published a draft statement of detailing how the FCA will exercise this power, the factors to which it will have regard and examples of when the use of this power may be appropriate.

 

The FCA will adopt a much more proactive and intrusive approach to financial services regulation; an approach far removed from the light touch regulation associated with the FSA. Following numerous scandals and considerable consumer detriment over recent years, intervention at the point of sale is no longer considered sufficient. The FCA will advocate much earlier regulatory intervention in the life cycle of retail financial products. The proposed product intervention rules will allow the FCA to assess products much earlier in the design process.

 

Temporary' product intervention rules can be put in place without consultation for up to 12 months. This means the FCA will be able to block the launch of certain products or prohibit any existing products or services.

 

When making temporary product intervention rules the FCA must consider a number of very vague factors and it must be:


  • Proportionate in relation to the potential detriment it is intending to prevent
  • Effective as a means of addressing the identified consumer detriment
  • Transparent in its operation, and
  • Beneficial for consumers

 

 

Popular products with a large customer base are the most likely to get swift product intervention.

 

Having identified a need for immediate action to protect consumers, the FCA can proceed virtually unchallenged with the creation and enforcement of temporary product intervention rules.

 

There are concerns that the FCA has too much freedom to use this power. The FCA could intervene to the extent that new products do not make it to market, and in so doing stifle innovation and product development.

Health insurance news: 16 May 2012